CITES
Overview
CITES is a venture capital firm based in Argentina that invests in deep-tech startups from the idea stage to Series A.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neocrop Technologies | Oct 2026 | Seed | Co-investor |
| Ab Astra Inc. | Jun 2026 | Pre Seed | Co-investor |
| Ergo Bioscience | Oct 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CITES based?
CITES is headquartered in Sunchales, Argentina.
When was CITES founded?
CITES was founded in 2013.
How many portfolio companies does CITES have?
CITES has 14 portfolio companies in Caplight's dataset.
What are some companies in CITES's portfolio?
Recent investments visible on Caplight include Neocrop Technologies, Ab Astra Inc., Ab Astra Inc., Ergo Bioscience, Ergo Bioscience.
What was CITES's most recent investment?
CITES's most recent investment on Caplight was in Neocrop Technologies in 2026.
What sectors does CITES focus on?
CITES focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does CITES focus on?
CITES typically invests at the Early stage.
What is CITES's AUM?
CITES's assets under management are estimated between $80.0M and $80.0M.